How to Prepare for a Meeting with EMA and Other European Regulatory Agencies for Drugs and Biologics

Date: December 12, 2016
Duration: 60 Minutes
Time: 12 PM EST

Europe is an attractive market for drugs and biologics. Formal meetings with the reviewers at the European Medicines Agency (EMA) and regulators at the Notified Bodies (NB) at European nations are perhaps one of the most important and useful resource available to the sponsors of medicinal products looking to get marketing approval in the Europe. EMA and other regulatory personnel participate in hundreds of meetings each year with applicants for all kinds of applications submitted to them for review. These meetings provide an opportunity to the industry to discuss product development strategies with the regulators and clarify interpretations of the regulations. Unlike US FDA, there are very few guidance documents to help companies prepare for meetings with the EMA and NB. European processes for meeting the regulators are vastly different from those at the US FDA and any other regulatory agencies in other parts of the World. Applicants need to understand the types of meetings, scope of each meeting, process to grant or reject meetings, and alternative mechanisms to obtain feedback. Meeting with regulators are critically needed to create an acceptable development strategy, and get timely feedback from reviewers. Meeting with regulators have been demonstrated to radically reduce the overall time to market for the regulated product.

Areas Covered in the Session:

Types of meetings and EMA and several Notified Bodies
Key guidelines available from regulators
Preparing the meeting request and meeting briefing book
Preparing for the meeting
Regulator’s review process and sponsor consultation
Logistics of the Regulatory meetings
Follow-up to the meeting with a regulatory agency
Do’s and don’ts of meetings with European regulators

Why should you attend:
This seminar will discuss the various kinds of regulatory meetings with EMA and NBs in several countries to highlight the factors governing grant or rejection of meeting, format, tone and conduct of such meetings. Depending on the kind of product being developed, sponsors can have various kinds of meetings with the regulators to gain insight about their expectations and nuances of the regulatory process whether Europe-wide or in specific countries of interest. Practical considerations for non-European companies will be discussed. The seminar will discuss the dos and don’ts of meetings with European regulators describing common mistakes and possible solutions using real-life case studies. Techniques in preparing for meetings with EMA and NBs, from the initial request to close-out of discussions post-meeting will be discussed.

Who will benefit:
This webinar will provide valuable assistance to all personnel in:

Regulatory affairs professionals
Senior management executives (CEO, COO, CFO, etc)
Project Managers
Clinical trial specialists
Regulatory Compliance Associates and Managers
People investing in drug and biologics products

Speaker: Mukesh Kumar

PhD, RAC | CEO, FDAMap

For more info, fill the box below. We will contact you within 24 hrs.

Webinar Fee

Single Registration

$199

Group Registration (5 Persons)

$699

Group Registration (10 Persons)

$1199

Prices are in US Dollars.
The registration fee includes: The live webinar & all related course materials.

Terms & Conditions to register for the Webinar

Your Registration for the workshop is subject to following terms and conditions. If you need any clarification before registering for this webinar please email us at info@fdamap.com

Payment

We accept credit card, debit card, and PayPal.

Cancellations & Substitutions:

Written cancellations through fax or email (from the person who has registered for this conference) received at least 5 business days prior to the start date of the event will receive a refund — less a $30 administration fee. No cancellations will be accepted — nor refunds issued — within 5 business days before the start date of the event. You may however, choose to substitute the webinar for which you are registered with some other webinar in the future.

On request by email or fax (before the seminar) a credit for the amount paid minus administration fees ($30) will be transferred to any future FDA Map event and a credit note will be issued. No-shows will be charged the full amount.

Webinar material will be uploaded on the website 24 hours before the scheduled date of the webinar. In case it is not available on the website due to some technical issues, we will email the material a few hours before the start of the webinar.

In the event FDA Map cancels the webinar, FDA Map will issue a full refund to all the registrants for that webinar. Some topics and speakers may be subject to change without notice.